Ahmad Miremadi
Overview
Explore the profile of Ahmad Miremadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1017
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng A, McClurg D, Wesley B, Zamani S, Black E, Miremadi A, et al.
Nat Commun
. 2024 May;
15(1):4533.
PMID: 38806493
No abstract available.
2.
Ng A, McClurg D, Wesley B, Zamani S, Black E, Miremadi A, et al.
Nat Commun
. 2024 May;
15(1):4074.
PMID: 38744814
Esophageal adenocarcinoma is a prominent example of cancer characterized by frequent amplifications in oncogenes. However, the mechanisms leading to amplicons that involve breakage-fusion-bridge cycles and extrachromosomal DNA are poorly understood....
3.
Gbegli E, Miremadi A, Serrao E, Sadler T
BJR Case Rep
. 2024 Mar;
10(2):uaae008.
PMID: 38529105
An Amyand hernia is an incarcerated inguinal hernia containing the appendix with or without appendicitis. This is a rare form of inguinal hernia, making up approximately 0.4%-1% of all cases....
4.
Black E, Ococks E, Devonshire G, Ng A, ODonovan M, Malhotra S, et al.
Gut
. 2023 Nov;
73(5):729-740.
PMID: 37989565
Objective: Whether gastric metaplasia (GM) of the oesophagus should be considered as Barrett's oesophagus (BO) is controversial. Given concern intestinal metaplasia (IM) may be missed due to sampling, the UK...
5.
Kim E, Chen P, Bressan D, Tripathi M, Miremadi A, di Pietro M, et al.
Cell Rep Methods
. 2023 Sep;
3(10):100595.
PMID: 37741277
Imaging mass cytometry (IMC) is a powerful technique capable of detecting over 30 markers on a single slide. It has been increasingly used for single-cell-based spatial phenotyping in a wide...
6.
Kim E, Chen P, Bressan D, Tripathi M, Miremadi A, di Pietro M, et al.
bioRxiv
. 2023 Mar;
PMID: 36865274
Motivation: Highly multiplexed tissue imaging allows visualization of the spatially resolved expression of multiple proteins at the single-cell level. Although imaging mass cytometry (IMC) using metal isotope-conjugated antibodies has a...
7.
Abujudeh S, Zeki S, van Lanschot M, Pusung M, Weaver J, Li X, et al.
BMC Genomics
. 2022 Aug;
23(1):599.
PMID: 35978291
Background: Somatic copy number alterations (SCNAs) are an important class of genomic alteration in cancer. They are frequently observed in cancer samples, with studies showing that, on average, SCNAs affect...
8.
Sundaram S, Kim E, Jones G, Sivagnanam S, Tripathi M, Miremadi A, et al.
Front Immunol
. 2022 Jun;
13:874255.
PMID: 35663986
Esophageal adenocarcinoma (EAC) develops from a chronic inflammatory environment across four stages: intestinal metaplasia, known as Barrett's esophagus, low- and high-grade dysplasia, and adenocarcinoma. Although the genomic characteristics of this...
9.
Lim D, Fernando S, Hyder S, Malhotra S, Miremadi A, Menon M
BJR Case Rep
. 2022 Mar;
7(6):20210103.
PMID: 35300226
small bowel adenocarcinoma (SBA) in the terminal ileum is the least common of the SBA types. However, its highest prevalence is found in the presence of Crohn's disease (CD). As...
10.
Januszewicz W, Pilonis N, Sawas T, Phillips R, ODonovan M, Miremadi A, et al.
Histopathology
. 2022 Mar;
80(7):1081-1090.
PMID: 35274753
Aims: Barrett's oesophagus with indefinite for dysplasia (BE-IND) is a subjective diagnosis with a low interobserver agreement (IOA) among pathologists and uncertain clinical implications. This study aimed to assess the...